A research team from POSTECH has developed a biodegradable polymer-based delivery system that efficiently transports mRNA.

Whilst COVID-19 has undoubtedly changed our day to day reality, the RNAi community is exploring the possibility of siRNA drugs to target highly conserved regions of coronavirus RNA. It is now more ...

The revolutionary study was featured on the cover of Wiley’s prestigious journal Advanced Science under the title “Intranasal Multiepitope PD-L1-siRNA-Based Nanovaccine: The Next-Gen COVID-19 ...

Those COVID vaccines that have experienced success ... small interfering ribonucleic acid (siRNA), and antisense oligonucleotides (ASOs), is Liberate Bio. siRNA therapeutics have already been ...

first using lipid nanoparticles to encapsulate the siRNA and deliver it to the cell — an approach that was later used in the mRNA-based COVID-19 vaccines — and then via conjugates: molecules ...

“COVID accelerated the acceptance of LNPs and ... LNPs can also carry small interfering RNA (siRNA), for example in patisiran, the first FDA-approved siRNA drug, which uses LNPs to deliver ...

Covid-19 is now ubiquitous – but hospitalisations seem to be on a downward trajectory. No one knows why. When virologists took their first peek at XEC, the Covid-19 variant which started to ...